RAS at these lower prices are looking very tempting.
Been a long term supporter of Jerko so a bit of bias here.
if Jerko is bullish on the NT project l'm listening.
I'll enter soon enough but my level of research is too early for me.
Neurology is compelling though
- Forums
- ASX - By Stock
- RAS
- RAS General Discussion
RAS General Discussion, page-6
-
- There are more pages in this discussion • 63 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAS (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.8¢ |
Change
0.002(12.5%) |
Mkt cap ! $2.424M |
Open | High | Low | Value | Volume |
1.6¢ | 1.8¢ | 1.6¢ | $2.602K | 151.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 34 | 1.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.1¢ | 55097 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 34 | 0.018 |
1 | 64189 | 0.017 |
1 | 269966 | 0.016 |
2 | 372775 | 0.015 |
4 | 355000 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.021 | 55097 | 1 |
0.024 | 70144 | 1 |
0.025 | 227780 | 2 |
0.051 | 193000 | 2 |
0.052 | 380516 | 1 |
Last trade - 14.51pm 15/07/2024 (20 minute delay) ? |
Featured News
RAS (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online